The FDA prasugrel review: Adjudication of myocardial infarction controversy

Victor L. Serebruany

doi:10.1159/000224157

The FDA prasugrel review: Adjudication of myocardial infarction controversy

Victor L. Serebruany

School of Medicine

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Original language	English (US)
Pages (from-to)	126-129
Number of pages	4
Journal	Cardiology
Volume	114
Issue number	2
DOIs	https://doi.org/10.1159/000224157
State	Published - Aug 2009

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Pharmacology (medical)

Access to Document

10.1159/000224157

Cite this

@article{a3901b20e5eb4cd0b712c1de608c7d09,

title = "The FDA prasugrel review: Adjudication of myocardial infarction controversy",

author = "Serebruany, {Victor L.}",

year = "2009",

month = aug,

doi = "10.1159/000224157",

language = "English (US)",

volume = "114",

pages = "126--129",

journal = "Cardiology",

issn = "0008-6312",

publisher = "Lippincott Williams and Wilkins Ltd.",

number = "2",

}

TY - JOUR

T1 - The FDA prasugrel review

T2 - Adjudication of myocardial infarction controversy

AU - Serebruany, Victor L.

PY - 2009/8

Y1 - 2009/8

UR - http://www.scopus.com/inward/record.url?scp=66449131840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66449131840&partnerID=8YFLogxK

U2 - 10.1159/000224157

DO - 10.1159/000224157

M3 - Article

C2 - 19506374

AN - SCOPUS:66449131840

SN - 0008-6312

VL - 114

SP - 126

EP - 129

JO - Cardiology

JF - Cardiology

IS - 2

ER -

The FDA prasugrel review: Adjudication of myocardial infarction controversy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this